Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease

Gut

Volumn 51, Issue 3, 2002, Pages 379-385

  Schreiber, S ^a   Rosenstiel, P ^a   Hampe, J ^a   Nikolaus, S ^a   Groessner, B ^a   Schottelius, A ^b,d   Kuhbacher T ^c   Hamling J ^a   Folsch U R ^a   Seegert, D ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MESALAZINE; OLSALAZINE; SALAZOSULFAPYRIDINE; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALLING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DNA BINDING; ENDOSCOPY; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS; BIOPSY; CELL NUCLEUS; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DNA; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MONOCYTES; NEUTROPHILS; PREDNISOLONE; PROTEINS; REPRESSOR PROTEINS; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0036716702     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.3.379     Document Type: Article

References (65)

1. Pathogenesis of Crohn's disease
2. Regulation of immune responses of the intestinal mucosa
3. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
4. Interleukin-10-deficient mice develop chronic enterocolitis
5. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
6. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
7. Intestinal permeability and the prediction of relapse in Crohn's disease
8. Suppression of T cell-mediated injury in human gut by interleukin 10: Role of matrix metalloproteinases
9. Inflammatory bowel disease (1)
10. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease
11. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease
12. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR)
13. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease
14. An interleukin 12-related cytokine is up-regulated in ulcerative colitis but not in Crohn's disease
15. Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis
16. Function and activation of NF-kappa B in the immune system
17. The NF-kappa B and I kappa B proteins: New discoveries and insights
18. Activation of transcription by IFN-gamma: Tyrosine phosphorylation of a 91-kD DNA binding protein
19. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
20. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
21. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
22. An interferon-gamma activation sequence mediates the transcriptional regulation of the IgG Fc receptor type IC gene by interferon-gamma
23. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha
24. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes
25. Intercellular adhesion molecule 1 (ICAM-1) is synergistically activated by TNF-alpha and IFN-gamma responsive sites
26. A family of cytokine-inducible inhibitors of signalling
27. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1
28. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
29. Activation of nuclear factor kappa B inflammatory bowel disease
30. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
31. On the Komolgorov-Smirnov test for normality with mean and variance unknown
32. On a test of whether one of two random variables is stachastically larger than the other
33. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
34. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
35. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
36. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
37. Mechanisms in failure of infliximab for Crohn's disease
38. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain
39. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma
40. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells
41. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation
42. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation
43. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins
44. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity
45. Gi2 alpha protein deficiency: A model of inflammatory bowel disease
46. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
47. The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease
48. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
49. Structure and function of a new STAT-induced STAT inhibitor
50. A new protein containing an SH2 domain that inhibits JAK kinases
51. CIS3/SOCS3/SS13 plays a negative regulatory role in STAT3 activation and intestinal inflammation
52. Expression of leukocyte adhesion molecules in the liver of patients with chronic hepatitis B virus infection
53. HLA antigens in inflammatory bowel disease
54. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: Reflection of mucosal inflammation
55. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease
56. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells
57. Tumor necrosis factor- α and interleukin - 1,3 in relapse of Crohn's disease
58. Clinical and histopathological features of dextran sulfate sodium induced acute and chronic colitis associated with dysplasia in rats
59. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
60. Mucosal flora in inflammatory bowel disease
61. Association between intraepithelial Escherichia coli and colorectal cancer
62. Association of NOD2 leucin-rich repeat variants with susceptibility to Crohn's disease
63. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
64. An insertion mutation in the NOD2 gene predisposes to Crohn's disease in German and British populations